Moving forward alpha-synuclein PFF models will be an important tool for evaluating how PD risk genes, like SNCA, in microglia, function in an already established disease state or in the context of compounding risk through exposure to environmental triggers for PD. This evidence concerns the gene SNCA and Parkinson disease.